海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
334件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo in postherpetic neuralgia
- Diagnosis of postherpetic neuralgia
- Denmark
- 2005-01-25
Authorised
- A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with combination therapy of LAF237 and pioglitazone to LAF237 monotherapy or pioglitazone monotherapy in drug naïve patients with type 2 diabetes - N/A
- Type II Diabetes
- Czech Republic, Italy, Slovakia, United Kingdom
- 2004-11-09
Authorised
- STUDY OF THE LONG TERM BIOLOGICAL EFFICACY AND TOLERABILITY OF VEDROP (VITAMIN E-TPGS FORMULATION) AFTER DAILY ORAL ADMINISTRATION IN 30 PAEDIATRIC PATIENTS WITH CYSTIC FIBROSIS - 1ORP2
- Paediatric patient who present a cystic fibrosis
- France
- 2007-03-26
Authorised
- This is a study to help understand how Baricitinib compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Czech Republic, Denmark, France, Germany, India, Italy, Japan, Mexico, Russian Federation, Taiwan
- 2017-09-04
Authorised
- Clonidine added to the current treatment of therapy resistant schizophrenia
- Schizophrenia, schizophreniform disorder, schizoaffective disorder;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Netherlands
- 2014-09-10
Authorised
- A study to see how effective and safe the drug Kappaproct is in patients with refractory ulcerative colitis when added to their standard care of treatment
- Chronic active treatment refractory ulcerative colitis MedDRA version: 14.1 Level: PT Classification code 10009900 Term: Colitis ulcerative System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Czech Republic, Germany, Hungary, Italy, Poland, United Kingdom
- 2011-08-11
Authorised
- Effect of pioglitazone in patienst with Adrenomyeloneuropathy.
- X-linked adrenoleukodystrophy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Spain
- 2013-09-12
Authorised
- Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate to Severe Atopic Dermatitis
- Moderate-to-Severe Atopic Dermatitis MedDRA version: 20.0 Level: PT Classification code 10012438 Term: Dermatitis atopic System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, Czech Republic, Germany, Poland, United Kingdom, United States
- 2018-06-20
Authorised
- A placebo-controlled study to assess efficacy, safety, tolerability and PK/PD of MOR106 in subjects with moderate to severe atopic dermatitis
- atopic dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Germany, Hungary, Poland, United Kingdom
- 2018-05-29
Authorised
- Efficacy, Safety, and Pharmacokinetic Profile of ANB020 in Adults with Moderate to Severe Atopic Dermatitis
- Moderate-to-Severe Atopic Dermatitis MedDRA version: 20.0 Level: PT Classification code 10012438 Term: Dermatitis atopic System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, Czech Republic, Germany, Poland, United Kingdom, United States
- 2018-05-23